78 related articles for article (PubMed ID: 7778358)
1. [Examination by image analysis for determining quantitative DNA parameters of serous papillary adenocarcinoma of the endometrium--a single case analysis].
Köhler U; Horn LG; Naumann G; Nenning H; Bilek K
Zentralbl Gynakol; 1995; 117(4):213-6. PubMed ID: 7778358
[TBL] [Abstract][Full Text] [Related]
2. The outcome of stage I-II clinically and surgically staged papillary serous and clear cell endometrial cancers when compared with endometrioid carcinoma.
Cirisano FD; Robboy SJ; Dodge RK; Bentley RC; Krigman HR; Synan IS; Soper JT; Clarke-Pearson DL
Gynecol Oncol; 2000 Apr; 77(1):55-65. PubMed ID: 10739691
[TBL] [Abstract][Full Text] [Related]
3. Epidemiologic and surgicopathologic findings of papillary serous and clear cell endometrial cancers when compared to endometrioid carcinoma.
Cirisano FD; Robboy SJ; Dodge RK; Bentley RC; Krigman HR; Synan IS; Soper JT; Clarke-Pearson DL
Gynecol Oncol; 1999 Sep; 74(3):385-94. PubMed ID: 10479498
[TBL] [Abstract][Full Text] [Related]
4. Establishment and characterization of human cell lines from a serous papillary adenocarcinoma of the endometrium.
Hirai Y; Kawaguchi T; Hasumi K; Kitagawa T; Noda T
Gynecol Oncol; 1994 Aug; 54(2):184-95. PubMed ID: 8063244
[TBL] [Abstract][Full Text] [Related]
5. [Variability of quantitative DNA parameters in endometrial carcinoma].
Köhler U; Naumann G; Nenning A; Taubert G; Bilek K
Zentralbl Gynakol; 1994; 116(11):609-13. PubMed ID: 7871910
[TBL] [Abstract][Full Text] [Related]
6. High-dose rate brachytherapy for Stage I/II papillary serous or clear cell endometrial cancer.
DuBeshter B; Estler K; Altobelli K; McDonald S; Glantz C; Angel C
Gynecol Oncol; 2004 Aug; 94(2):383-6. PubMed ID: 15297176
[TBL] [Abstract][Full Text] [Related]
7. Papillary serous and clear cell carcinoma limited to endometrial curettings in FIGO stage 1a and 1b endometrial adenocarcinoma: treatment implications.
Aquino-Parsons C; Lim P; Wong F; Mildenberger M
Gynecol Oncol; 1998 Oct; 71(1):83-6. PubMed ID: 9784324
[TBL] [Abstract][Full Text] [Related]
8. The relation between the results of cytophotometric examination of endometrial carcinoma and clinical course of these disease.
Köhler U; Taubert G; Bilek K; Nenning A
Arch Gynecol Obstet; 1992; 252(2):93-7. PubMed ID: 1471917
[TBL] [Abstract][Full Text] [Related]
9. The impact of age on long-term outcome in patients with endometrial cancer treated with postoperative radiation.
Jolly S; Vargas CE; Kumar T; Weiner SA; Brabbins DS; Chen PY; Floyd W; Martinez AA
Gynecol Oncol; 2006 Oct; 103(1):87-93. PubMed ID: 16545441
[TBL] [Abstract][Full Text] [Related]
10. Immunohistochemical profile of endometrial adenocarcinoma: a study of 61 cases and review of the literature.
Kounelis S; Kapranos N; Kouri E; Coppola D; Papadaki H; Jones MW
Mod Pathol; 2000 Apr; 13(4):379-88. PubMed ID: 10786803
[TBL] [Abstract][Full Text] [Related]
11. Role of DNA ploidy analysis in endometrial adenocarcinoma.
Jhala DN; Atkinson BF; Balsara GR; Hernandez E; Jhala NC
Ann Diagn Pathol; 2001 Oct; 5(5):267-73. PubMed ID: 11598854
[TBL] [Abstract][Full Text] [Related]
12. Clinicopathologic correlation of DNA flow cytometric content analysis (DFCA), surgical staging, and estrogen/progesterone receptor status in endometrial adenocarcinoma.
Konski AA; Domenico D; Irving D; Tyrkus M; Neisler J; Phibbs G; Mah J; Eggleston W
Am J Clin Oncol; 1996 Apr; 19(2):164-8. PubMed ID: 8610642
[TBL] [Abstract][Full Text] [Related]
13. [Uterine papillary serous carcinoma--one kind of special type of uterine endometrial carcinoma].
Wu M; Lang J; Guo L
Zhonghua Fu Chan Ke Za Zhi; 1996 Jan; 31(1):3-7. PubMed ID: 8758809
[TBL] [Abstract][Full Text] [Related]
14. [Papillary serous adenocarcinoma of the endometrium and ovary].
Zehani A; Ayadi-Kaddour A; Binous N; Mourali M; Ben Zineb N; El Mezni F
Tunis Med; 2012; 90(8-9):667-9. PubMed ID: 22987388
[No Abstract] [Full Text] [Related]
15. [Uterine papillary serous carcinoma and papillary endometrial carcinoma: analysis of clinical biological behaviors of 56 cases].
Sun X; Shi S; Sheng X
Zhonghua Fu Chan Ke Za Zhi; 1996 Jan; 31(1):8-11. PubMed ID: 8758810
[TBL] [Abstract][Full Text] [Related]
16. Stage II endometrioid adenocarcinoma of the endometrium: clinical implications of cervical stromal invasion.
Orezzoli JP; Sioletic S; Olawaiye A; Oliva E; del Carmen MG
Gynecol Oncol; 2009 Jun; 113(3):316-23. PubMed ID: 19345400
[TBL] [Abstract][Full Text] [Related]
17. Transitional cell carcinoma of the endometrium and endometrial carcinoma with transitional cell differentiation.
Lininger RA; Ashfaq R; Albores-Saavedra J; Tavassoli FA
Cancer; 1997 May; 79(10):1933-43. PubMed ID: 9149020
[TBL] [Abstract][Full Text] [Related]
18. [Serous-papillary endometrial carcinoma (clinico-morphological features)].
Urmancheeva AF; Ul'rikh EA; Neustadt EL; Zel'dovich DR; Dikareva AV
Vopr Onkol; 2002; 48(6):679-83. PubMed ID: 12530263
[TBL] [Abstract][Full Text] [Related]
19. Markov texture parameters as prognostic indicators in endometrial cancer.
Geisler JP; Wiemann MC; Zhou Z; Miller GA; Geisler HE
Gynecol Oncol; 1996 Aug; 62(2):174-80. PubMed ID: 8751546
[TBL] [Abstract][Full Text] [Related]
20. Serous papillary carcinoma of the endometrium arising from endometrial polyps: a clinical, histological, and immunohistochemical study of 13 cases.
Trahan S; Têtu B; Raymond PE
Hum Pathol; 2005 Dec; 36(12):1316-21. PubMed ID: 16311126
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
